Chongqing Genrix Biopharmaceutical Co (SHSE:688443) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688443 Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
48 GF Score
Price ¥25.03
! 4 Warning Signs
View Full Analysis

What is Chongqing Genrix Biopharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:688443
48GF Score
Chongqing Genrix Biopharmaceutical Co Ltd SHSE:688443
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chongqing Genrix Biopharmaceutical Co Business Description

Address No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan District, Chongqing, CHN, 401338
Chongqing Genrix Biopharmaceutical Co Ltd is a biopharmaceutical company engaged in the research & development, production and sales of antibody drugs. The company's pipeline includes product candidate that targets Autoimmune Diseases, Infectious Diseases, and Oncology.
48GF Score

Get the complete analysis for SHSE:688443

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.03
Price